Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow ...
Delays in treating a patient with an aggressive form of prostate cancer more than likely contributed to his disease advancing ...
Travel + Leisure on MSN
How Rick Steves’ approach to travel got him through his cancer journey—plus tips for jet lag and saving money on trips
After a routine blood test led to his diagnosis, the 70-year-old travel expert urges everyone to prioritize health exams.
A new international study has found that combining two cancer medicines may significantly slow the growth of a dangerous form ...
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...
Dr. Fizazi began by revisiting the role of docetaxel in the mHSPC setting, emphasizing that treatment benefit varies ...
When MRI offered no clear answer in suspected prostate cancer, the use of prostate-specific membrane antigen (PSMA)-PET/CT ...
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple ...
Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...
As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...
Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results